Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
Tempus AI in line for $200M from AstraZeneca cancer model deal
Tempus has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based model that could be used to develop new cancer drugs.
James Waldron
Apr 23, 2025 9:01am
ADCs to cell therapy: How AZ aims to 'redefine' oncology
Apr 9, 2025 11:44am
A closer look at pharma's top R&D budgets
Apr 4, 2025 9:34am
AZ, MSK adopt tech firm's data capture tool for phase 3 trial
Apr 1, 2025 3:05pm
AZ's oral PCSK9 inhibitor halves bad cholesterol in phase 2
Mar 31, 2025 12:00pm
Top 10 pharma R&D budgets in 2024
Mar 31, 2025 6:00am
